article thumbnail

Doctor Sues DEA for Right to Give Psilocybin to Ailing Patients

Project CBD

Psilocybin, the psychedelic mushroom extract, has been fast-tracked by the FDA to treat depression, but doctors still can’t use it in their practice.

DEA 344
article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 167
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves CBD-Containing Drug - Will the DEA Finally Step Up?

MJ Business Attorneys

Food and Drug Administration (FDA) approved Epidiolex, a drug containing Cannabidiol (CBD). Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. As the Controlled Substances Act (CSA) currently stands, CBD is still a Schedule I substance, which classifies CBD as having no medicinal uses.

DEA 113
article thumbnail

10 Tips for Buying Hemp-Derived CBD Products

Project CBD

With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate?

Hemp 203
article thumbnail

Hemp Litigation: DEA Sued Again

Canna Law Blog

The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. The DEA Does Not Want You To Worry About Its New Hemp Rule.

DEA 93
article thumbnail

The 2018 Farm Bill Does Not Support the DEA Interim Rule

Canna Law Blog

Unfortunately, the Drug Enforcement Administration (DEA) dropped a surprise interim hemp rule a few weeks ago, which took immediate effect and came as a shock to virtually everyone. The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. DEA Interim Final Rule: What Is “Synthetically Derived THC”?

DEA 86
article thumbnail

DEA Interim Final Rule: What Is “Synthetically Derived THC”?

Canna Law Blog

On Friday, the Drug Enforcement Administration (“DEA”) released an Interim Final Rule (the “ Rule ”) that, as we discussed , threatens the hemp industry by treating partially processed hemp extract not intended for consumption (also known as “intermediary hemp”) as a Schedule I controlled substance.

DEA 87